Literature DB >> 21874125

Commentary on 'Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)'

Angela M Reiersen1, Benjamin Handen.   

Abstract

Entities:  

Year:  2011        PMID： 21874125      PMCID： PMC3160736          DOI： 10.1002/ebch.786

Source DB:  PubMed          Journal:  Evid Based Child Health        ISSN： 1557-6272


× No keyword cloud information.
  9 in total

1.  Development and Psychometric Evaluation of the Treatment-Emergent Activation and Suicidality Assessment Profile.

Authors:  Jeannette M Reid; Eric A Storch; Tanya K Murphy; Danielle Bodzin; P Jane Mutch; Heather Lehmkuhl; Michael Aman; Wayne K Goodman
Journal:  Child Youth Care Forum       Date:  2010-02-04

2.  Clinical efficacy of fluvoxamine and functional polymorphism in a serotonin transporter gene on childhood autism.

Authors:  Yoko Sugie; Hideo Sugie; Tokiko Fukuda; Masataka Ito; Yumiko Sasada; Mutsumi Nakabayashi; Kazunobu Fukashiro; Takehiko Ohzeki
Journal:  J Autism Dev Disord       Date:  2005-06

3.  Fluoxetine in autism.

Authors:  R D Todd
Journal:  Am J Psychiatry       Date:  1991-08       Impact factor: 18.112

4.  Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders.

Authors:  Lawrence Scahill; Christopher J McDougle; Susan K Williams; Anastasia Dimitropoulos; Michael G Aman; James T McCracken; Elaine Tierney; L Eugene Arnold; Pegeen Cronin; Marco Grados; Jaswinder Ghuman; Kathleen Koenig; Kristen S L Lam; James McGough; David J Posey; Louise Ritz; Naomi B Swiezy; Benedetto Vitiello
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2006-09       Impact factor: 8.829

5.  A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism.

Authors:  Eric Hollander; Ann Phillips; William Chaplin; Karen Zagursky; Sherie Novotny; Stacey Wasserman; Rupa Iyengar
Journal:  Neuropsychopharmacology       Date:  2005-03       Impact factor: 7.853

6.  Medication patterns in patients with autism: temporal, regional, and demographic influences.

Authors:  Michael G Aman; Kristen S L Lam; Mary E Van Bourgondien
Journal:  J Child Adolesc Psychopharmacol       Date:  2005-02       Impact factor: 2.576

Review 7.  Co-occurrence of ADHD and autism spectrum disorders: phenomenology and treatment.

Authors:  Angela M Reiersen; Richard D Todd
Journal:  Expert Rev Neurother       Date:  2008-04       Impact factor: 4.618

8.  A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders.

Authors:  Anna J Esbensen; Jan S Greenberg; Marsha Mailick Seltzer; Michael G Aman
Journal:  J Autism Dev Disord       Date:  2009-05-12

9.  Activation adverse events induced by the selective serotonin reuptake inhibitor fluvoxamine in children and adolescents.

Authors:  Shauna P Reinblatt; Susan DosReis; John T Walkup; Mark A Riddle
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-04       Impact factor: 2.576
  9 in total
  2 in total

1.  Guidance for identification and treatment of individuals with attention deficit/hyperactivity disorder and autism spectrum disorder based upon expert consensus.

Authors:  Susan Young; Jack Hollingdale; Michael Absoud; Patrick Bolton; Polly Branney; William Colley; Emily Craze; Mayuri Dave; Quinton Deeley; Emad Farrag; Gisli Gudjonsson; Peter Hill; Ho-Lan Liang; Clodagh Murphy; Peri Mackintosh; Marianna Murin; Fintan O'Regan; Dennis Ougrin; Patricia Rios; Nancy Stover; Eric Taylor; Emma Woodhouse
Journal:  BMC Med       Date:  2020-05-25       Impact factor: 8.775

2.  Therapeutic effects of antidepressants for global improvement and subdomain symptoms of autism spectrum disorder: a systematic review and meta-analysis.

Authors:  Shun-Chin Liang; Cheuk-Kwan Sun; Yu-Shian Cheng; Pin-Yang Yeh; Hsin-Yi Fan; Weilun Chung; Ruu-Fen Tzang; Kuo-Chuan Hung; Hsien-Jane Chiu
Journal:  J Psychiatry Neurosci       Date:  2022-08-10       Impact factor: 5.699
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.